# Photodermatitis

- Category: acute
- Review status: reviewed (every claim checked against a document named on this page)
- Sources: DailyMed SetID 8274ca80-e7d3-4f4f-9901-cc5c589b4fef sections 1 and 2.2, https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=8274ca80-e7d3-4f4f-9901-cc5c589b4fef · Levocetirizine dihydrochloride tablets US prescribing information, sections 1 and 2 Dosage and Administration (DailyMed SetID 8274ca80-e7d3-4f4f-9901-cc5c589b4fef) · Sathe NC, Gillespie E. Photosensitivity and Photodermatoses. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2026 Jan-. Updated 2026 Jan 31. Bookshelf ID: NBK431072; PMID: 28613726.
- Verified date: 2026-08

## Verified against

- DailyMed SetID 8274ca80-e7d3-4f4f-9901-cc5c589b4fef sections 1 and 2.2, https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=8274ca80-e7d3-4f4f-9901-cc5c589b4fef

## Treatment metadata

- Levocetirizine — 5 mg — oral.solid

## Complete treatment card

```text
PHOTODERMATITIS
Sources: DailyMed SetID 8274ca80-e7d3-4f4f-9901-cc5c589b4fef sections 1 and 2.2, https://dailymed.nl
         m.nih.gov/dailymed/drugInfo.cfm?setid=8274ca80-e7d3-4f4f-9901-cc5c589b4fef · Levocetirizine
         dihydrochloride tablets US prescribing information, sections 1 and 2 Dosage and
         Administration (DailyMed SetID 8274ca80-e7d3-4f4f-9901-cc5c589b4fef) · Sathe NC, Gillespie
         E. Photosensitivity and Photodermatoses. In: StatPearls [Internet]. Treasure Island (FL):
         StatPearls Publishing; 2026 Jan-. Updated 2026 Jan 31. Bookshelf ID: NBK431072; PMID:
         28613726.
Review status: REVIEWED against the source listed above  (2026-08)

IS IT THIS? - reference only, to read alongside your own examination
  SYMPTOMS - what the patient reports (7)
    - Ask how soon after light the rash comes, whether it repeats, how it swings with season, and
      how long it lasts once exposure stops  [rash]
    - A reaction within minutes suggests solar urticaria; one appearing hours to days later suggests
      polymorphic light eruption or photoallergy  [rash · urticaria]
    - A long-standing rash with little seasonal swing points to lupus of the skin or chronic actinic
      dermatitis  [rash]
    - Review prescriptions, over-the-counter drugs, herbal remedies, topicals, fragrances, and plant
      or chemical contact at work or play
    - Thiazide diuretics and doxycycline are the usual drug culprits
    - Joint pains, mouth ulcers, Raynaud or tiredness suggest connective tissue disease; belly pain,
      nerve symptoms or dark urine suggest acute porphyria  [abdominal pain · fatigue · mouth
      ulcers]
    - In a child, poor growth, neurological problems or early cancers raise an inherited
      photosensitivity syndrome  [failure to thrive]
  SIGNS - what you find (8)
    - The rash sits on face, neck, V of the chest, backs of forearms and hands, sparing skin under
      clothing  [rash]
    - Sharp cut-offs at collar, jewellery, watch strap or hairline strongly support a light-driven
      rash  [rash]
    - Skin usually in the sun, like the face in polymorphic light eruption, may be spared through
      hardening  [rash]
    - Papules, plaques, vesicles and prurigo nodules fit the idiopathic group; wheals fit solar
      urticaria; eczematous plaques fit photoallergy or chronic actinic dermatitis  [blisters ·
      papules · plaques · urticaria · vesicles]
    - Ring-shaped plaques that worsen in the sun fit subacute cutaneous lupus  [plaques]
    - Blisters, fragile skin and scarring on exposed sites raise porphyria, above all porphyria
      cutanea tarda  [blisters · scarring]
    - Examine beyond the skin - scalp, nails, mucous membranes and for systemic disease
    - Abnormal nailfold capillaries support dermatomyositis; poikiloderma and sun damage suggest
      long-standing photosensitivity or a genodermatosis
  TESTS (12)
    - Testing follows the clinical suspicion and is tailored to the likeliest diagnosis
    - Start with history and examination, then targeted lab, photobiologic and histology testing
    - Phototesting, in specialist centres only, defines the action spectrum and reproduces the
      disease
    - Minimal erythema dose testing finds abnormal sensitivity to UVA or UVB and separates true
      photodermatoses from normal skin
    - Provocative phototesting over several days may reproduce the rash, but misses a high
      proportion of cases
    - Photopatch testing, alongside ordinary patch testing, is for suspected photoallergic contact
      dermatitis
    - ANA and ENA panels are for suspected connective tissue disease, not for routine screening
    - Blistering or painful photosensitivity means porphyrins in blood, urine and stool
    - Biopsy with histology and direct immunofluorescence helps where autoimmune, chronic actinic
      and idiopathic pictures overlap
    - Biopsy results are frequently non-specific and need the clinical context to read
    - Suspected inherited syndromes need specialist testing - cell survival after UV, DNA repair
      studies, gene sequencing
    - Finding these early matters - skin cancer risk is much raised and surveillance has to be close
  IF NOT THIS - what else fits (12)
    - Idiopathic group: polymorphous light eruption, actinic prurigo
    - Autoimmune group: cutaneous lupus and dermatomyositis
    - Metabolic group: the porphyrias and pellagra
    - Drug-induced: methotrexate, doxycycline
    - Genetic group: xeroderma pigmentosum
    - Persistent light-pattern rash: think cutaneous lupus, told apart by systemic features,
      serology and histology
    - Dermatomyositis where there is proximal muscle weakness or Gottron papules
    - Suspect a drug where medication changed recently and the border is sharp
    - Porphyria where there is blistering, fragile skin and scarring on exposed sites
    - Inherited syndromes begin early in life, with multisystem findings and raised cancer risk
    - Toxic epidermal necrolysis and Stevens-Johnson syndrome can take a light distribution
    - Dose, delay and distribution separate phototoxic from photoallergic reactions
  Source  StatPearls "Photosensitivity and Photodermatoses" - disease-level clinical article
  Status  traced to the source above

1. LEVOCETIRIZINE                                         [1st line]
   Adult    5 mg PO once daily in evening (2.5 mg once daily may suffice). - While symptoms persist;
            review at 4-6 weeks
   Peds     Age 6-11y: 2.5 mg (1/2 scored tablet) PO once daily in evening; age <6y: use oral
            solution.
   Source   DailyMed SetID 8274ca80-e7d3-4f4f-9901-cc5c589b4fef sections 1 and 2.2, https://dailymed
            .nlm.nih.gov/dailymed/drugInfo.cfm?setid=8274ca80-e7d3-4f4f-9901-cc5c589b4fef
   Why      Standard second-generation antihistamine dose for the itch of photodermatitis/sunburn
            dermatitis; dosing does not change with the trigger for the itch.
   Caution  Severe blistering sunburn, signs of drug-induced phototoxicity, or suspicion of an
            underlying connective tissue disease.
            Evening dosing suits itch that is often worse at night.
            Do not combine with cetirizine - levocetirizine is cetirizine's active component, so
            together they double the dose.
            Reduce to 2.5 mg in mild renal impairment.
            Does not treat severe blistering sunburn or an underlying phototoxic/connective tissue
            disease - it is symptomatic itch relief only.
   Egypt    ZALKEVOR 5 MG 10 F.C.TABS.       EL-OBOUR > RE...     5.50 EGP (0.55/unit)
            RHIPGIC 5 MG 30 F.C. TABS.       P & C LABS          19.50 EGP (0.65/unit)
            LERGOPAN 5 MG 10 F.C.TABS.       PHAROPHARMA          7.50 EGP (0.75/unit)
            LEVOCITRONE 5 MG 10 F.C.TABS.    EGYPHAR             21.00 EGP (2.10/unit)
            RAMATRIZINE  5 MG 30 F.C.TABS.   EGPI > RAMAPH...    96.00 EGP (3.20/unit)
            LEVOHISTAM 5 MG 30 F.C.TABS.     EGPI > UTOPIA      117.00 EGP (3.90/unit)
            ARAXILEVE 5 MG 30 ORO-DISPERSIBLE TABS. JEDCO INT. CO. FOR PHARMACEUTICA...    51.00 EGP
            LEVCET 5MG 20 ORODISSOLVABLE TABS. MARCYRL PHARMACEUTICAL INDUSTRIES (MPI)     85.00 EGP
            MERVOZA 2.5MG/5ML SYRUP 120 ML   GLOBAL NAPI P...     8.00 EGP
                -> ? strength differs, ? different route - not oral solid
            MODALLERGE 0.5MG/ML ORAL SOL.    EGPI > MODERN...     8.00 EGP
                -> ? strength differs, ? different route - not oral solid

Prices are indicative (dataset snapshot 2026-06); verify with the pharmacy.
```

---

Dawaa Reference is a reference for prescribers, not a medical device, and does not replace clinical judgement.

[Privacy policy](/privacy)
